Association study of the CACN1A4 (SCA6) triplet repeat and schizophrenia

Psychiatric Genetics

Volumn 9, Issue 2, 1999, Pages 111-113

  Breen, G ^a,b   Fox, H ^a   Glen, I ^d   Collier, D ^c   Shaw, D ^b   St Clair, David ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Craig Dunain Hospital   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Association; CACN1A4; CAG; Calcium channel; SCA6; Schizophrenia

Indexed keywords

CALCIUM CHANNEL;

ALLELE; ARTICLE; CHROMOSOME 19P; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; SCHIZOPHRENIA; TRINUCLEOTIDE REPEAT; UNITED KINGDOM;

EID: 0032741763     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199906000-00012     Document Type: Article

References (20)

1. American Psychiatric Association (1980). Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, DC: American Psychiatric Association.
2. Bassett AS, Honer WG (1994). Evidence for anticipation in schizophrenia. Am J Hum Genet 54:864-870.
3. Crow TJ (1997). Current status of linkage for schizophrenia: polygones of vanishingly small effect or multiple false positives? Am J Med Genet 74:99-103.
4. 2+) channel subunits. Genomics 30:605-609.
5. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN et al. (1996). Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87:607-617.
6. Gaitonde EJ, Sivagnanasundaram S, Morris AG, McKenna PJ, Mollon JD, Hunt DM (1997). The number of triplet repeats in five brain-expressed loci with CAG repeats is not associated with schizophrenia. Schizophr Res 25:111-116.
7. Guipponi M, Rivier F, Vigevano F, Beck C, Crespel A, Echenne B et al. (1997). Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 6:473-477.
8. Li T, Vallada HP, Liu X, Xie T, Tang X, Zhao J et al. (in press). Analysis of CAG/CTG repeat size in Chinese subjects with schizophrenia and bipolar affective disorder using the repeat expansion detection method. Biol Psychiatr.
9. Mannuzza S, Fyer AJ, Martin LY, Gallops MS, Endicott J, Gorman J et al. (1989). Reliability of anxiety assessment. Arch Gen Psychiatry 46:1093-1101.
10. McGuffin P, Owen MJ, Farmer, AE (1995). Genetic basis of schizophrenia. Lancet 346:678-682.
11. O'Donovan MC, Guy C, Craddock N, Bowen T, McKeon P, Macedo A et al. (1996). Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychol Med 26:1145-1153.
12. Ohara K, Tani K, Tsukamoto T, Ino A, Nagai M, Suzuki Y et al. (1997a). Three CAG trinucleotide repeats on chromosome 6 (D6S1014, D6S1015, and D6S1058) are not expanded in 30 families with schizophrenia. Neuropsychopharmacology 17:279-283.
13. Ohara K, Tani K, Tsukamoto T, Suzuki Y, Xu HD, Xu DS et al. (1997b). Exclusion of five trinucleotide repeat (CAG and CCG) expansions in 17 families with schizophrenia. Biol Psychiatry 42:756-759.
14. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM et al. (1996). Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca(2+) channel gene CACN1A4. Cell 87:543-552.
15. Sham P, Curtis D (1995). Monte-Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
16. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. (1995). A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 11:287-293.
17. Sugaya K, Sasanuma S, Nohata J, Kimura T, Fukagawa T, Nakamura Y et al. (1997). Gene organization of human NOTCH4 and (CTG)n polymorphism in this human counterpart gene of mouse proto-oncogene Int3. Gene 189:235-244.
18. Vincent JB, Kalsi G, Klempan T, Tatuch Y, Sherrington RP, Breschel T et al. (1998). No evidence of expansion of CAG or GAA repeats in schizophrenia families and monozygotic twins. Hum Genet 103:41-47.
19. Yamada K, Kanba S, Ashikari I, Ohnishi K, Yagi G, Asai M (1996). Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. J Clin Psychopharmacol 16:437-439.
20. Zhuchenko OO, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C et al. (1997). Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha-1A-voltage-dependent calcium channel. Nat Genet 15:62-69.